Pacemaker endocarditis: Clinical features and management of 60 consecutive cases

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 1, 2007, Pages 12-19

  Massoure, Pierre Laurent ^a   Reuter, Sylvain ^a   Lafitte, Stephane ^a   Laborderie, Julien ^a   Bordachard, Pierre ^a   Clementy, Jacques ^a   Roudaut, Raymond ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Endocarditis; Pacemaker; Transesophageal echocardiography

Indexed keywords

AMIKACIN; CLOXACILLIN; GENTAMICIN; RIFAMYCIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ASTHENIA; BACTERIUM CULTURE; CASE MANAGEMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DEFIBRILLATOR; DEVICE REMOVAL; ENDOCARDITIS; EVALUATION; FEMALE; FEVER; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; STAPHYLOCOCCUS; SYMPTOM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VEGETATION;

ADULT; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL;

EID: 33846286111     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00574.x     Document Type: Article

References (17)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Kappenberger L, Gras D, Tavazzi L. Cardiac heart-heart failure (care-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549.
2. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, et al., Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003; 289:2719-21.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
4. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG Jr. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004; 147:582-586.
5. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS. Pacemaker endocarditis: Report of 44 cases and review of the literature. Medicine 1994; 73:299-305.
6. Del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M, Mestres CA. Surgical treatment of pacemaker and defibrillator lead endocarditis. The impact of electrode lead extraction on outcome. Chest 2003; 124:1451-1459.
7. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacer S, et al. Systemic infection related to endocarditis on pacemaker leads: Clinical presentation and management. Circulation 1997; 95:2098-2107.
8. Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D, Mabo P, et al. Pacemaker leads infection: Echocardiographic features, management and outcome. Heart 1999; 83:82-87.
9. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Am J Med 1994; 96:200-209.
10. Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, Garcia M, Lefevre J, et al. Value and limitations of the Duke Criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 1999; 33:2023-2029.
11. Da Costa A, Kirkorian G, Chevalier P, Cerisier A, Chaividan T, Obadia JF, Etienne J, et al. Infectious complications of pacemaker implantation. Arch Mal Coeur 1998; 6:753-757.
12. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82:480-484.
13. Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J Am Soc Echocardiogr 2002; 15:1027-1028.
14. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, et al. Staphylococcus aureus bacteraemia in patients with permanent pacemakers or implantable cardioverters-defibrillators. Circulation 2001; 104:1029-1033.
15. Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: A single center experience and consequences of transvenous extraction. Am Heart J 2003; 146:339-344.
16. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, et al. Antibiotic prophylaxis for permanent pacemaker implantation. A meta analysis. Circulation 1998; 97:1796-1801.
17. Bertaglia B, Zerbo F, Zarbo S, Barzan D, Zoppo F, Pascotto P. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long-term infective complications. Pacing Clin Electrophysiol 2006; 29:29-33.